Kromek Group KMK.L · GBp

Its shares trade on LSE under the ticker KMK.L. It has been listed since 16 October 2013. In the fiscal year to 30 April 2026, it reported revenue of £27.1m and net income of £733,000. At that date it held total assets of £70.3m and shareholders' equity of £54.4m.

Kromek Group Plc engages in the development of radiation detectors based on cadmium zinc telluride. The firm develops radiation detectors based on cadmium zinc telluride. The firm's segments are UK Operations and US Operations. The firm designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets. The firm's solutions provide information on material composition and structure to enable the identification of cancerous tissues and hazardous materials (including explosives), and the analysis of radioactive materials. Its nuclear products include CPG, GR1-Gamma Ray Spectrometer, GR1A, SIGMA, TN15, RayMon10, Quant Air and RENA-Mini Development Platform. The company offers detectors and subcomponents for original equipment manufacturer (OEM) customers in the medical imaging market, including computed tomography (CT), single photon emission computed tomography (SPECT), positron emission tomography (PET) and bone mineral densitometry.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Rakesh SharmaIndependent Chairman of the Board£80,000
• Dr. Arnab BasuChief Executive Officer, Executive Director£313,000
• Ms. Claire BurgessChief Financial Officer, Executive Director, Company Secretary, since 2025
• Mr. Albertus BeumerChief Operating Officer, Executive Director, since 2020£296,000
• Mr. Lawrence KinetNon-Executive Independent Director£39,000
• Mr. Jerel WhittinghamNon-Executive Independent Director£42,000
• Mr. Christopher WilksNon-Executive Independent Director£43,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.